← Back to headlines
CEPI Backs Minapharm's Ebola Vaccine with $16.5 Million as Congo Outbreak Grows
The Coalition for Epidemic Preparedness Innovations (CEPI) has provided up to $16.5 million to Egypt's Minapharm to develop an experimental Ebola vaccine, as a new outbreak of the Bundibugyo strain spreads in the Democratic Republic of Congo.
27 Aug, 06:27 — 27 Aug, 14:36
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (38/100)3 sources25/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center3
Center (3)
actualite-cdReutersbloomberg
Right
Far R
Geographic diversity— 3 regions13/34
DR Congo1Intl1US1
Sources
Showing 3 of 3 sources
ReutersVery High4h ago
CEPI backs Minapharm's experimental Ebola vaccine with up to $16.5 million funding - Reuters
CEPI backs Minapharm's experimental Ebola vaccine with up to $16.5 million funding Reuters
Read full article →bloombergHigh10h ago
Ebola Vaccine Race Expands as Congo Bundibugyo Outbreak Grows
Efforts to develop a vaccine against the strain of Ebola driving the deadly outbreak in Democratic Republic of Congo are expanding, with an experimental shot developed by an Egypt-based pharmaceutical company set to advance toward human testing.
By Jason Gale
Read full article →actualite-cdMixed2h ago
UPDATED: Egypt’s Minapharm gets up to $16.5 mln to develop Ebola vaccine - Health - Egypt - Ahram Online
UPDATED: Egypt’s Minapharm gets up to $16.5 mln to develop Ebola vaccine - Health - Egypt Ahram Online
Read full article →Coverage Timeline
First report: bloomberg · 27 Aug, 06:27|Full coverage: 3 · 8h|Window: 8h
Left-leaningCenterRight-leaning
